CRVS Corvus Pharmaceuticals, Inc. - Common Stock
$15,53
Kurs · Aug 19, 2026
Fundamentaldaten per Aug 6, 2026
52W-Spanne
$5–$27
48% of range
Analystenbewertung
BUY
14 analysts
Kursziel
$33
+113% upside
P/E (TTM)
-29.3
ROE
-21.6%
Nettogewinnmarge
—
CRVS Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$15.53
Marktkapitalisierung
$1.16B
P/E (TTM)
-29.3
EPS (TTM)
$-0.53
Umsatz (TTM)
—
Dividendenrendite
—
ROE
-21.6%
Verschuldungsgrad
—
52W-Spanne
$5 – $27
CRVS Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
—
EPS
$-0.53
2019-12-31
→
2025-12-31
Freier Cashflow
$-33M
2018-12-31
→
2025-12-31
Margen
—
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
CRVS
Peer-Median
P/E (TTM)
-29.3
—
P/B (K/B)
19.0
5.2
Price / FCF (Kurs / FCF)
-35.2
—
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
CRVS
Peer-Median
ROA
-21.8%
-44.7%
ROE
-21.6%
-51.5%
ROIC
-70.2%
—
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
CRVS
Peer-Median
Current Ratio (Liquiditätsgrad)
6.2
9.5
Quick Ratio
0.5
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
CRVS
Peer-Median
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
CRVS
Peer-Median
CRVS Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
14 Analysten
- Starker Kauf 5 35,7%
- Kauf 8 57,1%
- Halten 1 7,1%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
7 Analysten · 2026-08-16
Median
$32.00
← Unter allen Zielen
$15.53
Tief
$27.00
Hoch
$42.00
Median-Ziel
$32.00
+106,1%
Mittelwert-Ziel
$33.14
+113,4%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
0.06%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 30. Juni 2026 | $-0.19 | $-0.16 | -0.03% |
| 31. März 2026 | $-0.15 | $-0.15 | -0.00% |
| 31. Dezember 2025 | $-0.15 | $-0.13 | -0.02% |
| 30. September 2025 | $-0.12 | $-0.14 | 0.02% |
| 30. Juni 2025 | $-0.10 | $-0.14 | 0.04% |
| 31. März 2025 | $0.21 | $-0.12 | 0.33% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| CRVS | $575M | -14.5 | — | — | -21.6% | — |
| NVAX | $1.09B | 2.6 | 64.7% | 39.2% | -977.1% | — |
| CGEM | $624M | -3.2 | — | — | -44.0% | — |
| MNKD | $1.75B | 283.5 | 22.2% | 1.7% | -11.1% | — |
| AKTS | — | — | — | — | — | — |
| GLUE | $1.03B | — | 63.5% | -31.2% | -15.4% | — |
| SANA | $1.09B | -4.2 | — | — | -172.3% | — |
| VOR | $506M | -0.2 | — | — | 83.4% | — |
| ODTX | — | — | — | — | — | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 12
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $34M | $19M | $17M | $24M | $29M | $32M | $38M | $39M | $46M | $29M | $11M | |
| SG&A Expense | $9M | $8M | $7M | $8M | $10M | $12M | $11M | $11M | $10M | $8M | $2M | |
| Operating Expenses | $43M | $28M | $23M | $33M | $39M | $44M | $49M | $49M | $57M | $37M | $14M | |
| Operating Income | $-43M | $-28M | $-23M | $-33M | $-39M | $-44M | $-49M | $-49M | $-57M | $-37M | $-14M | |
| Pretax Income | $-13M | $-59M | $-22M | $-31M | $-43M | $-6M | $-47M | $-47M | $-56M | $-36M | $-31M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-15M | $-62M | $-27M | $-41M | $-43M | $-6M | $-47M | $-47M | $-56M | $-36M | $-31M | |
| EPS (Basic) | $-0.19 | $-1.02 | $-0.56 | $-0.89 | $-1.03 | $-0.20 | $-1.59 | · | · | · | · | |
| EPS (Diluted) | $-0.53 | $-1.02 | $-0.56 | $-0.89 | $-1.03 | $-0.20 | $-1.59 | · | · | · | · | |
| Shares (Basic) | 78,964,842 | 60,985,165 | 48,025,274 | 46,553,511 | 41,854,110 | 29,478,878 | 29,349,810 | · | · | · | · | |
| Shares (Diluted) | 79,742,685 | 60,985,165 | 48,025,274 | 46,553,511 | 41,854,110 | 29,478,878 | 29,349,810 | · | · | · | · | |
| EBITDA | $-43M | $-27M | $-23M | $-32M | $-38M | $-43M | $-48M | $-48M | · | · | · |
Bilanz 23
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $5M | $9M | $13M | $13M | $63M | $16M | $5M | $39M | $45M | $5M | $4M | |
| Receivables | $37.0K | $75.0K | $26.0K | $588.0K | · | · | · | · | · | · | · | |
| Prepaid Expense | $1M | $2M | $781.0K | $773.0K | $1M | $1M | $1M | $992.0K | $1M | $1M | $1M | |
| Other Current Assets | $353.0K | $548.0K | $220.0K | $102.0K | $128.0K | $406.0K | $486.0K | $265.0K | $412.0K | $772.0K | $208.0K | |
| Current Assets | $58M | $54M | $28M | $44M | $71M | $45M | $79M | $116M | $91M | $136M | $96M | |
| PP&E (Net) | $220.0K | $151.0K | $236.0K | $353.0K | $451.0K | $906.0K | $1M | $2M | $3M | $3M | $2M | |
| PP&E (Gross) | $3M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $4M | $4M | $2M | |
| Accum. Depreciation | $3M | $5M | $5M | $5M | $4M | $4M | $3M | $2M | $2M | $729.0K | $135.0K | |
| Other Non-current Assets | $855.0K | $632.0K | $89.0K | $129.0K | $236.0K | $414.0K | $513.0K | $463.0K | $869.0K | $869.0K | · | |
| Total Assets | $71M | $69M | $46M | $68M | $109M | $86M | $84M | $118M | $95M | $140M | $98M | |
| Accounts Payable | $2M | $3M | $2M | $2M | $2M | $3M | $2M | $2M | $3M | $2M | $2M | |
| Accrued Liabilities | $6M | $4M | $4M | · | · | · | · | · | · | · | · | |
| Current Liabilities | $9M | $35M | $7M | $11M | $10M | $12M | $10M | $7M | $9M | $6M | $3M | |
| Capital Leases | $534.0K | $937.0K | · | $1M | $3M | $1M | $2M | · | · | · | · | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | $869.0K | $971.0K | $1M | $710.0K | |
| Total Liabilities | $10M | $36M | $7M | $12M | $12M | $13M | $13M | $8M | $10M | $7M | $4M | |
| Common Stock | $7.0K | $7.0K | $5.0K | $5.0K | $5.0K | $3.0K | $3.0K | $3.0K | $2.0K | $2.0K | · | |
| Paid-in Capital | $474M | $431M | · | · | · | · | · | · | · | · | · | |
| Retained Earnings | $-412M | $-397M | $-335M | $-308M | $-266M | $-223M | $-217M | $-170M | $-124M | $-68M | $-31M | |
| AOCI | $-896.0K | $-1M | $-967.0K | $-563.0K | $2M | $4.0K | $29.0K | $-34.0K | $-41.0K | $-39.0K | $-45.0K | |
| Stockholders' Equity | $61M | $33M | $39M | $56M | $97M | $72M | $71M | $110M | $85M | $133M | $-31M | |
| Liabilities + Equity | $71M | $69M | $46M | $68M | $109M | $86M | $84M | $118M | $95M | $140M | $98M | |
| Shares Outstanding | 74,696,629 | 67,899,779 | 49,038,582 | 46,553,511 | 46,553,511 | 28,372,634 | 27,953,233 | 29,323,930 | 21,041,250 | 20,922,428 | 1,431,615 |
Cashflow 12
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $105.0K | $85.0K | $151.0K | $367.0K | $460.0K | $632.0K | $743.0K | $847.0K | $842.0K | $594.0K | $148.0K | |
| Stock-based Comp | $5M | $3M | $2M | $3M | $4M | $6M | $7M | $7M | $6M | $4M | $428.0K | |
| Other Non-cash | $-23M | $34M | $796.0K | $11M | $2M | $-35M | $1M | $-2M | · | · | · | |
| Operating Cash Flow | $-33M | $-25M | $-24M | $-27M | $-37M | $-35M | $-37M | $-41M | $-46M | $-28M | $-11M | |
| CapEx | $174.0K | · | $34.0K | $269.0K | $5.0K | $76.0K | $25.0K | $355.0K | $266.0K | $2M | $2M | |
| Investing Cash Flow | $-8M | $-27M | $16M | $-23M | $22M | $45M | $3M | $-30M | $85M | $-43M | $-92M | |
| Stock Issued | · | $16M | · | · | $32M | · | · | $65M | $711.0K | $71M | · | |
| Net Stock Activity | · | $16M | · | · | $32M | · | · | $65M | · | · | · | |
| Financing Cash Flow | $36M | $49M | $8M | $0 | $62M | $1M | $24.0K | $65M | $1M | $71M | $95M | |
| Net Change in Cash | $-4M | $-4M | $-539.0K | $-50M | $47M | $11M | $-34M | $-6M | $40M | $945.0K | $-8M | |
| Taxes Paid | $0 | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $-33M | · | $-24M | $-27M | $-37M | $-35M | $-37M | $-41M | · | · | · |
Rentabilität 3
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -21.8% | -108.9% | -47.5% | -46.5% | -44.4% | -7.1% | -46.2% | -44.1% | · | · | · | |
| ROE | -21.6% | -277.0% | -65.1% | -68.4% | -42.8% | -10.5% | -61.6% | -41.0% | · | · | · | |
| ROIC | -70.2% | -84.6% | -60.5% | -58.0% | -39.8% | -60.7% | -68.7% | -44.6% | · | · | · |
Liquidität & Solvenz 2
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.2 | 1.5 | 4.1 | 4.1 | 7.4 | 3.7 | 7.8 | 16.4 | · | · | · | |
| Quick Ratio | 0.5 | 0.2 | 1.8 | 1.2 | 6.5 | 1.4 | 0.5 | 5.6 | · | · | · |
Bewertung (TTM) 8
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-15M | $-62M | $-27M | $-41M | $-43M | $-6M | $-47M | $-47M | $-56M | $-36M | · | |
| Market Cap | $575M | $363M | $86M | $40M | $112M | $101M | $152M | $108M | · | · | · | |
| P/E | -14.5 | -5.2 | -3.1 | -1.0 | -2.3 | -17.8 | -3.4 | · | · | · | · | |
| P/B | 9.4 | 11.2 | 2.2 | 0.7 | 1.2 | 1.4 | 2.1 | 1.0 | · | · | · | |
| P / Tangible Book | 9.4 | 11.2 | 2.2 | 0.7 | 1.2 | 1.4 | · | · | · | · | · | |
| P / Cash Flow | -17.5 | -14.3 | -3.6 | -1.5 | -3.1 | -2.9 | -4.1 | -2.6 | · | · | · | |
| P / FCF | -17.4 | · | -3.6 | -1.4 | -3.1 | -2.9 | -4.1 | -2.6 | · | · | · | |
| Earnings Yield | -6.9% | -19.1% | -31.8% | -104.7% | -42.7% | -5.6% | -29.2% | · | · | · | · |
Gewinn- und Verlustrechnung 13
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $16M | $11M | $10M | $8M | $8M | $7M | $6M | $5M | $4M | $4M | $4M | $4M | $4M | $5M | $10M | $5M | |
| SG&A Expense | $3M | $4M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Operating Expenses | $19M | $15M | $12M | $11M | $10M | $10M | $8M | $7M | $6M | $6M | $6M | $6M | $6M | $7M | $12M | $7M | |
| Operating Income | $-19M | $-15M | $-12M | $-11M | $-10M | $-10M | $-8M | $-7M | $-6M | $-6M | $-6M | $-6M | $-6M | $-7M | $-12M | $-7M | |
| Other Non-op | · | $1M | · | $415.0K | $2M | $25M | · | $-33M | $2M | $-552.0K | · | · | · | · | · | · | |
| Pretax Income | $-17M | $-13M | $-12M | $-10M | $-8M | $16M | $-10M | $-40M | $-4M | $-6M | $-5M | $-5M | $-5M | $-6M | · | · | |
| Income Tax | $0 | $0 | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-18M | $-14M | $-12M | $-10M | $-8M | $15M | $-12M | $-40M | $-4M | $-6M | $-7M | $-6M | $-7M | $-8M | $-15M | $-8M | |
| EPS (Basic) | $-0.19 | $-0.15 | $-0.18 | $-0.12 | $-0.10 | $0.21 | $-0.23 | $-0.60 | $-0.07 | $-0.12 | $-0.13 | $-0.12 | $-0.14 | $-0.17 | $-0.32 | $-0.18 | |
| EPS (Diluted) | $-0.19 | $-0.15 | $-0.18 | $-0.12 | $-0.10 | $-0.13 | $-0.23 | $-0.60 | $-0.07 | $-0.12 | $-0.13 | $-0.12 | $-0.14 | $-0.17 | $-0.32 | $-0.18 | |
| Shares (Basic) | 92,368,013 | 89,996,728 | -153,772,367 | 82,836,369 | 77,774,344 | 72,126,496 | -114,464,768 | 66,701,086 | 59,710,265 | 49,038,582 | -94,999,564 | 48,971,246 | 47,497,414 | 46,556,178 | 46,553,511 | 46,553,511 | |
| Shares (Diluted) | 92,368,013 | 89,996,728 | -156,020,542 | 82,836,369 | 77,774,344 | 75,152,514 | -114,464,768 | 66,701,086 | 59,710,265 | 49,038,582 | -94,999,564 | 48,971,246 | 47,497,414 | 46,556,178 | 46,553,511 | 46,553,511 | |
| EBITDA | $-19M | $-15M | · | $-11M | $-10M | $-10M | · | $-7M | $-6M | $-6M | · | $-6M | $-6M | $-7M | $-12M | $-7M |
Bilanz 22
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $19M | $40M | $5M | $3M | $15M | $5M | $9M | $5M | $15M | $7M | · | $20M | $8M | $10M | $25M | $28M | |
| Receivables | $6.0K | $43.0K | $37.0K | $32.0K | $86.0K | $79.0K | $75.0K | $70.0K | $35.0K | $26.0K | · | $11.0K | · | · | · | · | |
| Prepaid Expense | $6M | $3M | $1M | $1M | $1M | $1M | $2M | $1M | $977.0K | $697.0K | · | $915.0K | $893.0K | $655.0K | $1M | $2M | |
| Other Current Assets | $575.0K | $367.0K | $318.0K | $509.0K | $569.0K | $458.0K | $548.0K | $633.0K | $240.0K | $267.0K | · | $214.0K | $136.0K | $131.0K | $397.0K | $395.0K | |
| Current Assets | $221M | $240M | $58M | $67M | $76M | $45M | $54M | $43M | $48M | $23M | · | $33M | $38M | $36M | $51M | $59M | |
| PP&E (Net) | $830.0K | $282.0K | $220.0K | $221.0K | $249.0K | $165.0K | $151.0K | $171.0K | $192.0K | $213.0K | · | $264.0K | $294.0K | $330.0K | $447.0K | $527.0K | |
| PP&E (Gross) | $4M | $3M | $3M | $3M | $3M | $3M | $5M | $5M | $5M | $5M | · | $5M | $5M | $5M | $5M | $5M | |
| Accum. Depreciation | $3M | $3M | $3M | $3M | $3M | $3M | $5M | $5M | $5M | $5M | · | $5M | $5M | $5M | $5M | $4M | |
| Other Non-current Assets | $2M | $2M | $855.0K | $852.0K | $626.0K | $629.0K | $632.0K | $252.0K | $129.0K | $89.0K | · | $89.0K | $129.0K | $129.0K | $248.0K | $236.0K | |
| Total Assets | $239M | $253M | $71M | $80M | $89M | $59M | $69M | $59M | $65M | $40M | · | $52M | $58M | $58M | $80M | $93M | |
| Accounts Payable | $4M | $5M | $2M | $2M | $3M | $1M | $3M | $2M | $1M | $2M | · | $1M | $2M | $1M | $4M | $3M | |
| Accrued Liabilities | $9M | $7M | $6M | $6M | $5M | $4M | $4M | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $14M | $12M | $9M | $8M | $9M | $9M | $35M | $46M | $13M | $7M | · | $7M | $8M | $8M | $14M | $10M | |
| Capital Leases | $274.0K | $406.0K | $534.0K | $632.0K | $728.0K | $834.0K | $937.0K | · | · | · | · | $354.0K | $700.0K | $1M | $2M | $2M | |
| Total Liabilities | $14M | $13M | $10M | $9M | $9M | $10M | $36M | $46M | $13M | $7M | · | $8M | $9M | $9M | $16M | $12M | |
| Common Stock | $8.0K | $8.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $6.0K | $6.0K | $5.0K | · | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | |
| Paid-in Capital | $671M | $668M | $474M | · | · | · | $431M | · | · | · | · | · | · | · | · | · | |
| Retained Earnings | $-444M | $-426M | $-412M | $-400M | $-390M | $-382M | $-397M | $-385M | $-345M | $-340M | · | $-328M | $-322M | $-316M | $-298M | $-283M | |
| AOCI | $-1M | $-1M | $-896.0K | $-1M | $-1M | $-1M | $-1M | $-738.0K | $-1M | $-1M | · | $-1M | $-1M | $-434.0K | $-1M | $339.0K | |
| Stockholders' Equity | $225M | $241M | $61M | $72M | $80M | $49M | $33M | $12M | $51M | $33M | $39M | $44M | $49M | $49M | $65M | $80M | |
| Liabilities + Equity | $239M | $253M | $71M | $80M | $89M | $59M | $69M | $59M | $65M | $40M | · | $52M | $58M | $58M | $80M | $93M | |
| Shares Outstanding | 84,120,944 | 84,090,424 | 74,696,629 | 74,681,872 | 74,514,039 | 68,169,461 | 67,899,779 | 62,580,031 | 62,551,281 | 49,038,582 | · | 49,038,582 | 48,898,362 | 46,568,511 | 46,553,511 | 46,553,511 |
Cashflow 11
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $34.0K | $29.0K | $26.0K | $28.0K | $29.0K | $22.0K | $20.0K | $21.0K | $21.0K | $23.0K | $28.0K | $30.0K | $36.0K | $57.0K | $94.0K | $92.0K | |
| Stock-based Comp | $3M | $3M | $2M | $1M | $1M | $1M | $813.0K | $733.0K | $768.0K | $689.0K | $572.0K | $546.0K | $537.0K | $492.0K | $658.0K | $675.0K | |
| Other Non-cash | · | $639.0K | · | · | · | $-25M | · | · | · | $-168.0K | · | · | · | $-787.0K | · | · | |
| Operating Cash Flow | $-15M | $-10M | $-9M | $-10M | $-6M | $-8M | $-8M | $-6M | $-5M | $-5M | $-5M | $-5M | $-5M | $-8M | $-7M | $-6M | |
| CapEx | $582.0K | $91.0K | $25.0K | $0 | $113.0K | $36.0K | · | · | · | · | $0 | $0 | $0 | $34.0K | $265.0K | · | |
| Investing Cash Flow | $-6M | $-145M | $11M | $-3M | $-20M | $4M | $-6M | $-4M | $-18M | $-7.0K | $-2M | $18M | $-4M | $5M | $3M | $3M | |
| Stock Issued | $0 | $189M | · | · | · | · | $0 | $0 | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | $189M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $166.0K | $191M | $20.0K | $360.0K | $36M | $279.0K | $19M | $50.0K | · | · | $0 | $335.0K | $8M | $4.0K | · | · | |
| Net Change in Cash | $-21M | $36M | $2M | $-12M | $10M | $-4M | $4M | $-10M | $7M | $-5M | $-7M | $12M | $-2M | $-4M | $-4M | $-3M | |
| Free Cash Flow | · | $-10M | · | · | · | $-8M | · | · | · | · | · | · | · | $-8M | · | · |
Rentabilität 3
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -10.9% | -8.8% | · | -14.6% | -10.4% | 30.5% | · | -72.6% | -7.0% | -11.6% | · | -9.1% | -8.6% | -9.9% | -14.9% | -8.3% | |
| ROE | -11.8% | -9.4% | · | -24.1% | -12.2% | 36.8% | · | -141.9% | -8.5% | -13.9% | · | -11.0% | -10.0% | -11.4% | -17.5% | -9.5% | |
| ROIC | · | -6.2% | · | · | · | · | · | · | · | -18.7% | · | · | · | · | · | · |
Liquidität & Solvenz 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 16.2 | 19.8 | · | 8.3 | 8.9 | 4.9 | · | 0.9 | 3.6 | 3.4 | · | 4.5 | 4.8 | 4.3 | 3.7 | 5.8 | |
| Quick Ratio | 1.4 | 3.3 | · | 0.4 | 1.7 | 0.5 | · | 0.1 | 1.1 | 1.1 | · | 2.8 | 1.0 | 1.2 | 1.8 | 2.8 |
Bewertung (TTM) 8
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-50M | $-17M | · | $-43M | $-37M | $-35M | · | $-56M | $-22M | $-26M | · | $-35M | $-38M | $-39M | $-42M | $-39M | |
| Market Cap | $1.26B | $1.23B | · | $550M | $298M | $217M | · | $330M | $114M | $87M | · | $72M | $112M | $42M | $38M | $46M | |
| P/E | -26.7 | -29.3 | · | -7.8 | -4.4 | -3.5 | · | -5.8 | -4.0 | -3.2 | · | -1.9 | -2.8 | -1.1 | -0.9 | -1.2 | |
| P/B | 5.6 | 5.1 | · | 7.7 | 3.7 | 4.4 | · | 26.6 | 2.2 | 2.6 | · | 1.6 | 2.3 | 0.9 | 0.6 | 0.6 | |
| P / Tangible Book | 5.6 | 5.1 | · | 7.7 | 3.7 | 4.4 | · | 26.6 | 2.2 | 2.6 | · | 1.6 | 2.3 | 0.9 | 0.6 | 0.6 | |
| P / Cash Flow | · | -118.6 | · | · | · | -26.2 | · | · | · | -16.9 | · | · | · | -5.2 | · | · | |
| P / FCF | · | -117.6 | · | · | · | -26.1 | · | · | · | · | · | · | · | -5.2 | · | · | |
| Earnings Yield | -3.8% | -3.4% | · | -12.9% | -22.5% | -28.9% | · | -17.2% | -24.7% | -30.9% | · | -51.4% | -35.4% | -93.4% | -107.5% | -80.8% |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Nettoergebnis | $-15M | $-62M | $-27M | $-41M | $-43M |
| Verwässerte EPS | $-0.53 | $-1.02 | $-0.56 | $-0.89 | $-1.03 |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Liquiditätsgrad | 6.2 | 1.5 | 4.1 | 4.1 | 7.4 |
| Quick Ratio | 0.5 | 0.2 | 1.8 | 1.2 | 6.5 |
Cashflow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Freier Cashflow | $-33M | — | $-24M | $-27M | $-37M |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 189 Einreicher · $850.4M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 47 (-22 vs. Vorquartal) | 28 (+7 vs. Vorquartal) | 68 (+9 vs. Vorquartal) | 40 (+13 vs. Vorquartal) | +3.3M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| ORBIMED ADVISORS LLC | $107.045.190 | 7.165.006 | 12,59% | Aktien |
| STATE STREET CORP | $66.842.920 | 4.474.091 | 7,86% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $49.193.087 | 3.292.710 | 5,78% | Aktien |
| ADAMS STREET PARTNERS LLC | $48.937.703 | 3.275.616 | 5,75% | Aktien |
| Vivo Capital, LLC | $41.918.891 | 2.805.816 | 4,93% | Aktien |
| PERCEPTIVE ADVISORS LLC | $39.851.569 | 2.667.441 | 4,69% | Aktien |
| Deep Track Capital, LP | $37.229.569 | 2.491.939 | 4,38% | Aktien |
| BRAIDWELL LP | $31.766.892 | 2.126.298 | 3,74% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $28.099.301 | 1.880.810 | 3,30% | Aktien |
| Foresite Capital Management VI LLC | $27.358.621 | 1.831.233 | 3,22% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $23.775.864 | 1.590.939 | 2,80% | Aktien |
| Hood River Capital Management LLC | $23.482.767 | 1.571.805 | 2,76% | Aktien |
| GOLDMAN SACHS GROUP INC | $19.824.246 | 1.326.924 | 2,33% | Aktien |
| Boxer Capital Management, LLC | $16.434.000 | 1.100.000 | 1,93% | Aktien |
| Catalio Capital Management, LP | $16.148.467 | 1.080.888 | 1,90% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $15.656.896 | 1.047.985 | 1,84% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $12.172.365 | 814.750 | 1,43% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $11.731.008 | 785.208 | 1,38% | Aktien |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $11.205.000 | 750.000 | 1,32% | Aktien |
| Eversept Partners, LP | $11.175.030 | 747.994 | 1,31% | Aktien |
| EMERALD ADVISERS, LLC | $10.244.104 | 685.683 | 1,20% | Aktien |
| BANK OF AMERICA CORP /DE/ | $10.073.400 | 674.257 | 1,18% | Aktien |
| DCF Advisers, LLC | $9.524.250 | 637.500 | 1,12% | Aktien |
| Blue Owl Capital Holdings LP | $9.092.484 | 608.600 | 1,07% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $8.739.900 | 585.000 | 1,03% | Kaufoption |
| EMERALD MUTUAL FUND ADVISERS TRUST | $7.864.252 | 526.389 | 0,92% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $7.776.688 | 520.528 | 0,91% | Aktien |
| RA CAPITAL MANAGEMENT, L.P. | $6.723.000 | 450.000 | 0,79% | Aktien |
| Nextech Invest Ltd. | $6.723.000 | 450.000 | 0,79% | Aktien |
| CITADEL ADVISORS LLC | $6.675.192 | 446.800 | 0,78% | Kaufoption |
| CITADEL ADVISORS LLC | $5.945.388 | 397.951 | 0,70% | Aktien |
| Jump Financial, LLC | $4.682.196 | 313.400 | 0,55% | Aktien |
| BARCLAYS PLC | $4.589.313 | 307.183 | 0,54% | Aktien |
| Trexquant Investment LP | $4.427.424 | 296.347 | 0,52% | Aktien |
| DIADEMA PARTNERS LP | $4.404.476 | 294.811 | 0,52% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $4.101.030 | 274.500 | 0,48% | Verkaufsoption |
| Polymer Capital Management (HK) LTD | $3.939.110 | 263.662 | 0,46% | Aktien |
| Brevan Howard Capital Management LP | $3.739.348 | 250.291 | 0,44% | Aktien |
| SPHERA FUNDS MANAGEMENT LTD. | $3.659.717 | 244.961 | 0,43% | Aktien |
| Spruce Street Capital LP | $3.459.880 | 231.585 | 0,41% | Aktien |
| SEB Asset Management AB | $3.388.938 | 226.837 | 0,40% | Aktien |
| VICTORY CAPITAL MANAGEMENT INC | $3.298.169 | 220.761 | 0,39% | Aktien |
| Connor, Clark & Lunn Investment Management Ltd. | $3.253.185 | 217.750 | 0,38% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $3.109.298 | 208.119 | 0,37% | Aktien |
| CITADEL ADVISORS LLC | $2.959.614 | 198.100 | 0,35% | Verkaufsoption |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2.848.177 | 190.641 | 0,33% | Aktien |
| Caption Management, LLC | $2.838.600 | 190.000 | 0,33% | Kaufoption |
| F/m Investments LLC | $2.497.445 | 167.165 | 0,29% | Aktien |
| JANE STREET GROUP, LLC | $2.094.588 | 140.200 | 0,25% | Kaufoption |
| BlackRock, Inc. | $2.085.251 | 139.575 | 0,25% | Aktien |
| DIADEMA PARTNERS LP | $1.992.996 | 133.400 | 0,23% | Kaufoption |
| Swiss National Bank | $1.889.910 | 126.500 | 0,22% | Aktien |
| Aquatic Capital Management LLC | $1.762.920 | 118.000 | 0,21% | Aktien |
| ADAR1 Capital Management, LLC | $1.749.489 | 117.101 | 0,21% | Aktien |
| CITIGROUP INC | $1.664.555 | 111.416 | 0,20% | Aktien |
| Caption Management, LLC | $1.664.316 | 111.400 | 0,20% | Verkaufsoption |
| MARSHALL WACE, LLP | $1.501.082 | 100.474 | 0,18% | Aktien |
| SIMPLEX TRADING, LLC | $1.379.604 | 92.343 | 0,16% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $1.322.845 | 90.420 | 0,16% | Aktien |
| RHUMBLINE ADVISERS | $1.285.128 | 86.020 | 0,15% | Aktien |
| ALPS ADVISORS INC | $1.274.980 | 85.340 | 0,15% | Aktien |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $1.238.631 | 82.907 | 0,15% | Aktien |
| Seven Fleet Capital Management LP | $1.238.377 | 82.890 | 0,15% | Aktien |
| TD Asset Management Inc | $1.233.984 | 82.596 | 0,15% | Aktien |
| Rafferty Asset Management, LLC | $1.217.520 | 81.494 | 0,14% | Aktien |
| SEI INVESTMENTS CO | $1.195.290 | 80.006 | 0,14% | Aktien |
| Avidity Partners Management LP | $1.195.200 | 80.000 | 0,14% | Aktien |
| Persistent Asset Partners Ltd | $1.117.452 | 74.796 | 0,13% | Aktien |
| Bank of New York Mellon Corp | $1.094.011 | 73.227 | 0,13% | Aktien |
| Propel Bio Management, LLC | $1.051.477 | 70.380 | 0,12% | Aktien |
| TOWERVIEW LLC | $1.045.800 | 70.000 | 0,12% | Aktien |
| D. E. Shaw & Co., Inc. | $967.768 | 64.777 | 0,11% | Aktien |
| Caption Management, LLC | $956.668 | 64.034 | 0,11% | Aktien |
| JACKSON SQUARE CAPITAL, LLC | $952.769 | 63.773 | 0,11% | Aktien |
| WELLS FARGO & COMPANY/MN | $920.155 | 61.590 | 0,11% | Aktien |
| TUDOR INVESTMENT CORP ET AL | $902.376 | 60.400 | 0,11% | Kaufoption |
| Ancora Advisors LLC | $847.442 | 56.723 | 0,10% | Aktien |
| SEVEN GRAND MANAGERS, LLC | $747.000 | 50.000 | 0,09% | Aktien |
| GROUP ONE TRADING LLC | $721.482 | 48.292 | 0,08% | Aktien |
| Vanguard Global Advisers, LLC | $712.459 | 47.688 | 0,08% | Aktien |
| VANGUARD ASSET MANAGEMENT, Ltd | $660.632 | 44.219 | 0,08% | Aktien |
| Squarepoint Ops LLC | $660.423 | 44.205 | 0,08% | Aktien |
| Y-Intercept (Hong Kong) Ltd | $653.909 | 43.769 | 0,08% | Aktien |
| TEMA ETFS LLC | $613.675 | 79.698 | 0,07% | Aktien |
| PROFUND ADVISORS LLC | $613.197 | 41.044 | 0,07% | Aktien |
| MetLife Investment Management, LLC | $592.341 | 39.648 | 0,07% | Aktien |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $559.159 | 37.427 | 0,07% | Aktien |
| AVITY INVESTMENT MANAGEMENT INC. | $555.021 | 37.150 | 0,07% | Aktien |
| Engineers Gate Manager LP | $538.124 | 36.019 | 0,06% | Aktien |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $494.365 | 33.090 | 0,06% | Aktien |
| STATE OF WISCONSIN INVESTMENT BOARD | $414.719 | 27.759 | 0,05% | Aktien |
| Optimize Financial Inc | $410.518 | 28.060 | 0,05% | Aktien |
| Virtus Investment Advisers, LLC | $409.759 | 27.427 | 0,05% | Aktien |
| ACT CAPITAL MANAGEMENT, LLC | $403.380 | 27.000 | 0,05% | Aktien |
| Invesco Ltd. | $402.917 | 26.969 | 0,05% | Aktien |
| NEW YORK STATE COMMON RETIREMENT FUND | $374.994 | 25.100 | 0,04% | Aktien |
| SIMON QUICK ADVISORS, LLC | $373.500 | 25.000 | 0,04% | Aktien |
| PEAK6 LLC | $352.584 | 23.600 | 0,04% | Kaufoption |
| WINTON GROUP Ltd | $346.608 | 23.200 | 0,04% | Aktien |
| TUDOR INVESTMENT CORP ET AL | $328.560 | 21.992 | 0,04% | Aktien |
Unternehmensinsider 19 Insider · 8 Führungskräfte · 10 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Richard A Miller MD | President and CEO | 31. März 2023 A | 1.163.507 | 0 | 0 | $0 |
| Leiv Lea | Chief Financial Officer | 21. Dezember 2018 P | 24.700 | 0 | 0 | $0 |
| Mehrdad Mobasher | Chief Medical Officer | 28. Januar 2019 A | — | 0 | 0 | $0 |
| Daniel W. Hunt | SVP, Chief Business Officer | 12. Dezember 2018 A | — | 0 | 0 | $0 |
| William Benton Jones | SVP, Pharmaceutical Development | 12. Dezember 2018 A | — | 0 | 0 | $0 |
| Erik J. Verner | V.P., Chemistry Research | 12. Dezember 2018 A | — | 0 | 0 | $0 |
| Joseph J Buggy | EVP Discovery Research | 12. Dezember 2018 A | — | 0 | 0 | $0 |
| Jason V Coloma | SVP, Chief Business Officer | 8. Juni 2016 A | — | 0 | 0 | $0 |
| David Scott Moore | Direktor | 11. Juni 2026 A | 21.700 | 1 | 0 | $250.201 |
| Richard Van Den Broek | Direktor | 11. Juni 2026 A | — | 0 | 0 | $0 |
| Linda S Grais | Direktor | 11. Juni 2026 A | — | 0 | 0 | $0 |
| Peter A. Thompson | Direktor | 11. Juni 2026 A | 210.000 | 0 | 0 | $0 |
| Ian T Clark | Direktor | 11. Juni 2026 A | — | 0 | 0 | $0 |
| Steve E. Krognes | Direktor | 20. Juni 2019 A | — | 0 | 0 | $0 |
| Scott W Morrison | Direktor | 20. Juni 2019 A | — | 0 | 0 | $0 |
| Terry P Gould | Direktor | 20. Juni 2019 A | 126.806 | 0 | 0 | $0 |
| ORBIMED ADVISORS LLC | Direktor | 29. März 2016 C | 5.258.450 | 0 | 0 | $0 |
| Adams Street Partners, LLC | 10%-Eigentümer | 11. August 2022 A | 126.806 | 0 | 0 | $0 |
| Novo Holdings A/S | 10%-Eigentümer | 8. Juli 2020 S | 1.389.498 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 5 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Adams Street Partners, LLC, Adams Street 2011 Direct Fund LP, Adams Street 2012 Direct Fund LP, Adams Street 2013 Direct Fund LP, Adams Street 2014 Direct Fund LP, Adams Street 2015 Direct Venture/Growth Fund LP, Adams Street 2016 Direct Venture/Growth Fund LP, Adams Street 2017 Direct Venture/Growth Fund LP, Adams Street 2018 Direct Venture/Growth Fund LP, Adams Street Venture/Growth Fund VI LP ×2 Einreichungen | 5. Februar 2026 | 3,90% | Änderung | — | SEC |
| ORBIMED ADVISORS LLC, ORBIMED CAPITAL GP V LLC ×13 Einreichungen | 27. Januar 2026 | 10,30% | Änderung | — | SEC |
| Novo Holdings A/S ×2 Einreichungen | 9. Juli 2020 | — | Erste Einreichung | — | SEC |
| Novo Holdings A/S (formerly known as Novo A/S) | 31. Januar 2019 | — | Erste Einreichung | — | SEC |
| Novo A/S | 30. März 2016 | — | Erste Einreichung | Passive Anlage | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 36 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| LFSC · RBB Fund, Inc. | 1,95% | 165.305 NS | 31. Mai 2026 | N-PORT |
| BBC · ETFis Series Trust I | 1,34% | 32.976 NS | 30. April 2026 | N-PORT |
| CANC · Tema ETF Trust | 0,76% | 108.477 NS | 31. Mai 2026 | N-PORT |
| SBIO · ALPS ETF Trust | 0,66% | 86.347 NS | 31. Mai 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,35% | 121.201 NS | 30. April 2026 | N-PORT |
| BIB · ProShares Trust | 0,05% | 3.054 NS | 31. Mai 2026 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0,04% | 29.277 NS | 31. Mai 2026 | N-PORT |
| RSSL · Global X Funds | 0,03% | 27.905 NS | 30. April 2026 | N-PORT |
| ITWO · ProShares Trust | 0,02% | 3.029 NS | 31. Mai 2026 | N-PORT |
| UWM · ProShares Trust | 0,01% | 2.369 NS | 31. Mai 2026 | N-PORT |
| URTY · ProShares Trust | 0,01% | 2.398 NS | 31. Mai 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 60 NS | 31. Mai 2026 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0,00% | 27.317 NS | 31. Mai 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,00% | 1.515 NS | 31. Mai 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | — | — | 15. Juli 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | — | — | 15. Juli 2026 | Täglich |
| VFMO · VANGUARD WELLINGTON FUND | — | — | 30. Juli 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | — | — | 15. Juli 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | — | — | 15. Juli 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | — | — | 15. Juli 2026 | Täglich |
| ITOT · iShares Trust | — | — | 5. August 2026 | Täglich |
| IWV · iShares Trust | — | — | 18. August 2026 | Täglich |
| IWO · iShares Trust | — | — | 18. August 2026 | Täglich |
| IWM · iShares Trust | — | — | 18. August 2026 | Täglich |
| IBB · iShares Trust | — | — | 18. August 2026 | Täglich |
| IWC · iShares Trust | — | — | 18. August 2026 | Täglich |
| PKW · Invesco Exchange-Traded Fund Trust | — | — | 4. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | — | — | 20. Juli 2026 | Täglich |
| ISCB · iShares Trust | — | — | 5. August 2026 | Täglich |
| ISCG · iShares Trust | — | — | 5. August 2026 | Täglich |
| ISCV · iShares Trust | — | — | 5. August 2026 | Täglich |
| SMLF · iShares Trust | — | — | 10. August 2026 | Täglich |
| IDNA · iShares Trust | — | — | 12. August 2026 | Täglich |
| TECB · iShares Trust | — | — | 5. August 2026 | Täglich |
| WSML · iShares Trust | — | — | 5. August 2026 | Täglich |
| IBBQ · Invesco Exchange-Traded Fund Trust … | — | — | 20. Juli 2026 | Täglich |